755 research outputs found
A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington's Disease
Understanding the order and progression of change in biomarkers of neurodegeneration is essential to detect the effects of pharmacological interventions on these biomarkers. In Huntington’s disease (HD), motor, cognitive and MRI biomarkers are currently used in clinical trials of drug efficacy. Here for the first time we use directly compare data from three large observational studies of HD (total N = 532) using a probabilistic event-based model (EBM) to characterise the order in which motor, cognitive and MRI biomarkers become abnormal. We also investigate the impact of the genetic cause of HD, cytosine-adenine-guanine (CAG) repeat length, on progression through these stages. We find that EBM uncovers a broadly consistent order of events across all three studies; that EBM stage reflects clinical stage; and that EBM stage is related to age and genetic burden. Our findings indicate that measures of subcortical and white matter volume become abnormal prior to clinical and cognitive biomarkers. Importantly, CAG repeat length has a large impact on the timing of onset of each stage and progression through the stages, with a longer repeat length resulting in earlier onset and faster progression. Our results can be used to help design clinical trials of treatments for Huntington’s disease, influencing the choice of biomarkers and the recruitment of participants
An image-based model of brain volume biomarker changes in Huntington's disease
Objective: Determining the sequence in which Huntington's disease biomarkers become abnormal can provide important insights into the disease progression and a quantitative tool for patient stratification. Here, we construct and present a uniquely fine-grained model of temporal progression of Huntington's disease from premanifest through to manifest stages. Methods: We employ a probabilistic event-based model to determine the sequence of appearance of atrophy in brain volumes, learned from structural MRI in the Track-HD study, as well as to estimate the uncertainty in the ordering. We use longitudinal and phenotypic data to demonstrate the utility of the patient staging system that the resulting model provides. Results: The model recovers the following order of detectable changes in brain region volumes: putamen, caudate, pallidum, insula white matter, nonventricular cerebrospinal fluid, amygdala, optic chiasm, third ventricle, posterior insula, and basal forebrain. This ordering is mostly preserved even under cross-validation of the uncertainty in the event sequence. Longitudinal analysis performed using 6 years of follow-up data from baseline confirms efficacy of the model, as subjects consistently move to later stages with time, and significant correlations are observed between the estimated stages and nonimaging phenotypic markers. Interpretation: We used a data-driven method to provide new insight into Huntington's disease progression as well as new power to stage and predict conversion. Our results highlight the potential of disease progression models, such as the event-based model, to provide new insight into Huntington's disease progression and to support fine-grained patient stratification for future precision medicine in Huntington's disease
Early effects of androgen deprivation on bone and mineral homeostasis in adult men: a prospective cohort study
Objective: Long-term androgen deprivation therapy (ADT) negatively influences bone. The short
term effects on bone and mineral homeostasis are less known. Therefore, we aimed to investigate
the early effects of ADT on calcium/phosphate homeostasis and bone turnover.
Design: Prospective cohort study
Methods: Eugonadal adult male sex offenders, who were referred for ADT to the endocrine
outpatient clinic, received cyproterone acetate. Changes in blood markers of calcium/phosphate
homeostasis and bone turnover between baseline and first follow-up visit were studied.
Results: Of 26 screened patients, 17 were included. The median age was 44 (range 20-75) years. The
median time interval between baseline and first follow-up was 13 (6-27) weeks. Compared to
baseline, an 81% decrease was observed for median total testosterone (to 3.4 nmol/L (0.4-12.2);
P<0.0001) and free testosterone (to 0.06 nmol/L (0.01-0.18); P<0.0001). Median total estradiol
decreased 71% (to 17.6 pmol/L (4.7-35.6); P<0.0001). Increased serum calcium (P<0.0001) and
phosphate (P=0.0016) was observed, paralleled by decreased PTH (P=0.0156) and 1,25
dihydroxyvitamin D3 (P=0.0134). The stable calcium isotope ratio (δ44/42Ca) decreased (P=0.0458),
indicating net calcium loss from bone. Bone-specific alkaline phosphatase and osteocalcin decreased
(P<0.0001 and P=0.0056, respectively), periostin tended to decrease (P=0.0500) whereas sclerostin
increased (P<0.0001), indicating suppressed bone formation. Serum bone resorption markers
(TRAcP5b, CTX) were unaltered.
Conclusions: In adult men, calcium release from the skeleton occurs early following sex steroid
deprivation, reflecting early bone resorption. The increase of sclerostin and reduction of bone
formation markers, without changes in resorption markers, suggests a dominant negative effect on
bone formation in the acute phase
Robust markers and sample sizes for multi‐centre trials of Huntington's disease
Objective: The identification of sensitive biomarkers is essential to validate therapeutics for Huntington disease (HD).
We directly compare structural imaging markers across the largest collective imaging HD dataset to identify a set of
imaging markers robust to multicenter variation and to derive upper estimates on sample sizes for clinical trials in HD.
Methods: We used 1 postprocessing pipeline to retrospectively analyze T1-weighted magnetic resonance imaging
(MRI) scans from 624 participants at 3 time points, from the PREDICT-HD, TRACK-HD, and IMAGE-HD studies. We
used mixed effects models to adjust regional brain volumes for covariates, calculate effect sizes, and simulate possible
treatment effects in disease-affected anatomical regions. We used our model to estimate the statistical power of possible treatment effects for anatomical regions and clinical markers.
Results: We identified a set of common anatomical regions that have similarly large standardized effect sizes (>0.5)
between healthy control and premanifest HD (PreHD) groups. These included subcortical, white matter, and cortical
regions and nonventricular cerebrospinal fluid (CSF). We also observed a consistent spatial distribution of effect size by
region across the whole brain. We found that multicenter studies were necessary to capture treatment effect variance;
for a 20% treatment effect, power of >80% was achieved for the caudate (n = 661), pallidum (n = 687), and nonventricular CSF (n = 939), and, crucially, these imaging markers provided greater power than standard clinical markers.
Interpretation: Our findings provide the first cross-study validation of structural imaging markers in HD, supporting the
use of these measurements as endpoints for both observational studies and clinical trial
Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin
Background:
Griffithsin, a 121-residue protein isolated from a red algal Griffithsia sp., binds high mannose N-linked glycans of virus surface glycoproteins with extremely high affinity, a property that allows it to prevent the entry of primary isolates and laboratory strains of T- and M-tropic HIV-1. We used the sequence of a portion of griffithsin's sequence as a design template to create smaller peptides with antiviral and carbohydrate-binding properties.
Methodology/Results:
The new peptides derived from a trio of homologous β-sheet repeats that comprise the motifs responsible for its biological activity. Our most active antiviral peptide, grifonin-1 (GRFN-1), had an EC50 of 190.8±11.0 nM in in vitro TZM-bl assays and an EC50 of 546.6±66.1 nM in p24gag antigen release assays. GRFN-1 showed considerable structural plasticity, assuming different conformations in solvents that differed in polarity and hydrophobicity. Higher concentrations of GRFN-1 formed oligomers, based on intermolecular β-sheet interactions. Like its parent protein, GRFN-1 bound viral glycoproteins gp41 and gp120 via the N-linked glycans on their surface.
Conclusion:
Its substantial antiviral activity and low toxicity in vitro suggest that GRFN-1 and/or its derivatives may have therapeutic potential as topical and/or systemic agents directed against HIV-1
Recommended from our members
Genome-wide association study identifies 30 loci associated with bipolar disorder.
Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P < 1 × 10-4 in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P < 5 × 10-8) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder
CHUVA ÁCIDA
Este trabalho apresentará um estudo sobre o ph da chuva da cidade de Jaraguá do Sul, Santa Catarina. Mesmo Jaraguá do Sul contando com uma elevada frota de carros e uma forte indústria, não foram identificados estudos na área, por este motivo um estudo como este se mostra de suma importância. Foram realizadas coletas de amostras em 5 pontos extremos da cidade e o valor médio de ph encontrado foi de 5,6. Não sendo possível concluir que a chuva ocorrida em Jaraguá do Sul é ácida, pois ao cair à chuva arrasta consigo componentes da atmosfera, assim é considerada uma chuva ácida uma chuva que apresente valores de ph inferiores a 5,6. Assim sendo, caberiam mais estudos para dizer com mais exatidão se Jaraguá do Sul - Santa Catarina apresenta chuva ácida
Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease
Current teaching suggests that many patients are at risk for prolonged bleeding during and following invasive dental procedures, due to an acquired coagulopathy from systemic disease and/or from medications. However, treatment standards for these patients often are the result of long-standing dogma with little or no scientific basis. The medical history is critical for the identification of patients potentially at risk for prolonged bleeding from dental treatment. Some time-honoured laboratory tests have little or no use in community dental practice. Loss of functioning hepatic, renal, or bone marrow tissue predisposes to acquired coagulopathies through different mechanisms, but the relationship to oral haemostasis is poorly understood. Given the lack of established, science-based standards, proper dental management requires an understanding of certain principles of pathophysiology for these medical conditions and a few standard laboratory tests. Making changes in anticoagulant drug regimens are often unwarranted and/or expensive, and can put patients at far greater risk for morbidity and mortality than the unlikely outcome of postoperative bleeding. It should be recognised that prolonged bleeding is a rare event following invasive dental procedures, and therefore the vast majority of patients with suspected acquired coagulopathies are best managed in the community practice setting
Lattice Boltzmann simulations of soft matter systems
This article concerns numerical simulations of the dynamics of particles
immersed in a continuum solvent. As prototypical systems, we consider colloidal
dispersions of spherical particles and solutions of uncharged polymers. After a
brief explanation of the concept of hydrodynamic interactions, we give a
general overview over the various simulation methods that have been developed
to cope with the resulting computational problems. We then focus on the
approach we have developed, which couples a system of particles to a lattice
Boltzmann model representing the solvent degrees of freedom. The standard D3Q19
lattice Boltzmann model is derived and explained in depth, followed by a
detailed discussion of complementary methods for the coupling of solvent and
solute. Colloidal dispersions are best described in terms of extended particles
with appropriate boundary conditions at the surfaces, while particles with
internal degrees of freedom are easier to simulate as an arrangement of mass
points with frictional coupling to the solvent. In both cases, particular care
has been taken to simulate thermal fluctuations in a consistent way. The
usefulness of this methodology is illustrated by studies from our own research,
where the dynamics of colloidal and polymeric systems has been investigated in
both equilibrium and nonequilibrium situations.Comment: Review article, submitted to Advances in Polymer Science. 16 figures,
76 page
- …